Literature DB >> 7869402

Compliance with public sector HIV medical care.

P Kissinger1, D Cohen, W Brandon, J Rice, A Morse, R Clark.   

Abstract

Despite the availability of free or low-cost public sector human immunodeficiency virus (HIV) health-care services, important inequities in utilization exist. This study examined two measures of compliance with HIV medical care: attendance of scheduled outpatient visits and use of the emergency room. Clients of two public HIV outpatient clinics were followed from time of health-care initiation to either death or the end of the study. The association of race, sex, age, and injection drug use (IDU) with these measures were examined in multivariate logistic regression. Models were adjusted for disease staging at time of entry and for length of follow-up time in clinic. Of 1824 clients followed, 15% failed to attend scheduled visits and 18.1% had at least one emergency room visit. Clients who missed visits were more likely to be African American, to have a history of IDU, and to have a CD4 cell count < 500/mm3 or an acquired immunodeficiency syndrome (AIDS)-defining opportunistic infection at entry. They were also more likely to have > or = 12 months of follow-up time in the HIV clinic, but were less likely to have entered into health care from an early intervention clinic. Clients who had at least one emergency room visit were more likely to be African American, female, IDU, and under 22 years of age; these clients were also more likely to have entered with CD4 < 200/mm3 or with an opportunistic infection, and to have > or = 12 months of follow-up in the clinic.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7869402      PMCID: PMC2607741     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  19 in total

Review 1.  Prophylaxis of opportunistic infections in individuals infected with HIV.

Authors:  R S Klein
Journal:  AIDS       Date:  1989       Impact factor: 4.177

2.  Seeking professional help for personal problems: black Americans' use of health and mental health services.

Authors:  H W Neighbors
Journal:  Community Ment Health J       Date:  1985

Review 3.  The diagnosis of cytomegalovirus retinitis.

Authors:  J N Bloom; A G Palestine
Journal:  Ann Intern Med       Date:  1988-12-15       Impact factor: 25.391

4.  Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.

Authors:  L Solomon; R Frank; D Vlahov; J Astemborski
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

5.  Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984 through 1987.

Authors:  J E Harris
Journal:  JAMA       Date:  1990-01-19       Impact factor: 56.272

6.  The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

Authors:  M A Fischl; D D Richman; M H Grieco; M S Gottlieb; P A Volberding; O L Laskin; J M Leedom; J E Groopman; D Mildvan; R T Schooley
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

7.  Case-mix groups for VA hospital-based home care.

Authors:  M E Smith; C R Baker; L G Branch; R C Walls; R M Grimes; J M Karklins; M Kashner; R Burrage; A Parks; P Rogers
Journal:  Med Care       Date:  1992-01       Impact factor: 2.983

8.  Acquired immunodeficiency syndrome. Ophthalmic manifestations in ambulatory patients.

Authors:  P R Rosenberg; A E Uliss; G H Friedland; C A Harris; C B Small; R S Klein
Journal:  Ophthalmology       Date:  1983-08       Impact factor: 12.079

9.  The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Authors:  M A Fischl; D D Richman; N Hansen; A C Collier; J T Carey; M F Para; W D Hardy; R Dolin; W G Powderly; J D Allan
Journal:  Ann Intern Med       Date:  1990-05-15       Impact factor: 25.391

10.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

View more
  16 in total

1.  Survival patterns among HIV+ individuals based on health care utilization.

Authors:  K J Welch; A Morse
Journal:  J Natl Med Assoc       Date:  2001-06       Impact factor: 1.798

2.  Risk factors for missed HIV primary care visits among men who have sex with men.

Authors:  Lara Traeger; Conall O'Cleirigh; Margie R Skeer; Kenneth H Mayer; Steven A Safren
Journal:  J Behav Med       Date:  2011-11-09

3.  The role of at-risk alcohol/drug use and treatment in appointment attendance and virologic suppression among HIV(+) African Americans.

Authors:  Chanelle J Howe; Stephen R Cole; Sonia Napravnik; Jay S Kaufman; Adaora A Adimora; Beth Elston; Joseph J Eron; Michael J Mugavero
Journal:  AIDS Res Hum Retroviruses       Date:  2014-01-20       Impact factor: 2.205

4.  Evaluating the Impact of a HIV Low-Risk Express Care Task-Shifting Program: A Case Study of the Targeted Learning Roadmap.

Authors:  Linh Tran; Constantin T Yiannoutsos; Beverly S Musick; Kara K Wools-Kaloustian; Abraham Siika; Sylvester Kimaiyo; Mark J van der Laan; Maya Petersen
Journal:  Epidemiol Methods       Date:  2016-11-10

5.  Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort.

Authors:  V E Stone; M Y Mauch; K Steger; S F Janas; D E Craven
Journal:  J Gen Intern Med       Date:  1997-03       Impact factor: 5.128

6.  Delays in seeking HIV care due to competing caregiver responsibilities.

Authors:  M D Stein; S Crystal; W E Cunningham; A Ananthanarayanan; R M Andersen; B J Turner; S Zierler; S Morton; M H Katz; S A Bozzette; M F Shapiro; M A Schuster
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

7.  Missed visits and mortality among patients establishing initial outpatient HIV treatment.

Authors:  Michael J Mugavero; Hui-Yi Lin; James H Willig; Andrew O Westfall; Kimberly B Ulett; Justin S Routman; Sarah Abroms; James L Raper; Michael S Saag; Jeroan J Allison
Journal:  Clin Infect Dis       Date:  2009-01-15       Impact factor: 9.079

8.  African American race and HIV virological suppression: beyond disparities in clinic attendance.

Authors:  Chanelle J Howe; Sonia Napravnik; Stephen R Cole; Jay S Kaufman; Adaora A Adimora; Beth Elston; Joseph J Eron; Michael J Mugavero
Journal:  Am J Epidemiol       Date:  2014-05-08       Impact factor: 4.897

9.  Racial disparities in HIV virologic failure: do missed visits matter?

Authors:  Michael J Mugavero; Hui-Yi Lin; Jeroan J Allison; Thomas P Giordano; James H Willig; James L Raper; Nelda P Wray; Stephen R Cole; Joseph E Schumacher; Susan Davies; Michael S Saag
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

10.  Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database.

Authors:  Preeyaporn Srasuebkul; Poh Lian Lim; Man Po Lee; Nagalingeswaran Kumarasamy; Jialun Zhou; Thira Sirisanthana; Patrick C K Li; Adeeba Kamarulzaman; Shinichi Oka; Praphan Phanuphak; Saphonn Vonthanak; Tuti P Merati; Yi-Ming A Chen; Somnuek Sungkanuparph; Goa Tau; Fujie Zhang; Christopher K C Lee; Rossana Ditangco; Sanjay Pujari; Jun Y Choi; Jeffery Smith; Matthew G Law
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.